Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
NASA funds new tech for upcoming 'Super Hubble' to search for alien life: 'We intend to move with urgency' - 2IDF strikes terror infrastructure across Iran, attack reported on Kashan airport
- 3I was about to film a movie with Glen Powell when my hair started falling out in clumps. Alopecia has made me unrecognizable as an actor.
- 4Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- 5Countdown to Artemis II: What to know about NASA's moon mission
- The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- Manual for Notorious Fragrances: Immortal Aromas
- See the moon shine with Saturn in the southern sky after sunset Dec. 26
- Vote in favor of your #1 sort of juice
- Child influencers helped power a booming industry. It's time for a reckoning.
- War in Iran could exacerbate German housing crisis, minister warns
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- I served on the expert committee that advised the government on new dietary guidelines – most of our recommendations were ignored
- A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
